Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Based on available data and mechanism of action, retatrutide appears most relevant for: People with significant obesity (BMI 35+) who want maximum weight reduction and haven't achieved their goals on semaglutide or tirzepatide People with type 2 diabetes who need both glycemic control and meaningful weight loss People who have plateaued on existing GLP-1 therapy and are wondering if a more powerful triple agonist would move the needle People focused on metabolic longevity , where reducing adiposity, improving insulin sensitivity, and lowering chronic inflammation are all high-priority goals If you're someone chasing a 5-10 lb cosmetic goal, retatrutide is probably overkill
Some discontinuations were attributed to perceived excessive weight loss, which is a unique scenario not typically seen in obesity trials
Ahsan H, Ali A, Ali R
doi:10.1155/2016/9130979 [PubMed]
US$ 26.83
US$ 24.44
US$ 27.12
US$ 22.56
US$ 23.64
